Stay updated on Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.

Latest updates to the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, signaling a minor update to the study record. This change reflects a non-substantive update to the page (likely metadata or UI adjustments) rather than edits to the study data or content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.5.4 now appears on the page, replacing Revision: v3.5.3. This indicates a site version update rather than a modification to the study information presented.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page’s footer revision/version has been updated from **v3.5.0** to **v3.5.3**, reflecting a site release update without altering the study details.SummaryDifference0.0%

- Check65 days agoChange DetectedReplaced the study site entry Padua, Veneto, Italy, 35128 with Padova, Veneto, Italy, 35128. The city name is updated to the local spelling in the locations list.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page adds a reference to Hepatocellular carcinoma and includes the Genetic and Rare Diseases Information Center as a resource. It also updates the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.